BioAge Labs, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BIOA Nasdaq 2830 bioagelabs.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioAge Labs, Inc.

BioAge halts ongoing Phase II trial of obesity drug due to liver concerns - Dec 9th, 2024 2:28 pm
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns - Dec 9th, 2024 12:41 pm
BioAge shares tumble after decision to halt obesity drug study - Dec 7th, 2024 11:34 am
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity - Dec 6th, 2024 9:35 pm
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic - Dec 5th, 2024 9:30 pm
Why BioAge Labs (BIOA) is the Best All-Time Low Stock to Buy Right Now? - Dec 4th, 2024 9:47 pm
BioAge Labs to Present at Upcoming Investor Conferences - Nov 21st, 2024 9:30 pm
BioAge Labs Reports Strong Q3 2024 Achievements - Nov 13th, 2024 4:01 am
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates - Nov 7th, 2024 9:30 pm
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024 - Nov 4th, 2024 2:00 pm
BioAge Labs to Present at Jefferies London Healthcare Conference - Oct 24th, 2024 1:00 pm
Wall Street analysts initiate coverage of BioAge Labs - Oct 21st, 2024 2:53 pm
Prediction: These 2 Stocks Could Soar in 2025 - Oct 17th, 2024 1:45 pm
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock - Oct 12th, 2024 6:31 pm
RA Capital Management, L.P. Acquires New Stake in Bioage Labs Inc - Oct 8th, 2024 1:10 am
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October - Oct 5th, 2024 11:15 am
This IPO Biotech Stock Could Be the Next Eli Lilly - Oct 3rd, 2024 1:05 pm
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement - Oct 1st, 2024 8:30 pm
BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPO - Sep 26th, 2024 8:08 pm
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq - Sep 26th, 2024 12:25 pm